SRPT

Biotechnology Edmund Ingham PEPG SRPT Uncategorized

PepGen: Stock Slides On FDA Study Hold – I’m Firmly On The Sidelines

Mar 5, 2026

Biotechnology RGNX SRPT Uncategorized

Regenxbio dealt win by appeals court in patent spat with Sarepta

Feb 20, 2026

Biotechnology SRPT Uncategorized

Sarepta rises on three-year Elevidys data

Jan 26, 2026

Biotechnology SRPT Uncategorized

Sarepta jumps on upcoming release of 3-year Elevidys data

Jan 23, 2026

sarepta-guides-q4-sales-below-estimates

Biotechnology SRPT Uncategorized

Sarepta guides Q4 sales below estimates

Jan 12, 2026

On the Move Comments Sarepta Therapeutics (SRPT) estimates total net product revenue of $369.6M ($380.61M...

sarepta-a-new-outperform-at-wedbush-as-selloff-overdone

Biotechnology SRPT Uncategorized

Sarepta a new outperform at Wedbush as selloff overdone

Dec 9, 2025

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your...